ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Beads Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-8R9622
Home | Market Reports | Health| Health Conditions| Cancer
Global Drug Eluting Beads Market Insights and Forecast to 2028
BUY CHAPTERS

Global Drug Eluting Beads Market Research Report 2025

Code: QYRE-Auto-8R9622
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biocompatibles
BTG International
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic Inc
Surefire Medical
Terumo
Merit Medical Systems

Drug Eluting Beads Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drug Eluting Beads Market

Drug Eluting Beads Market

The global market for Drug Eluting Beads was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Beads, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Beads.
The Drug Eluting Beads market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Eluting Beads market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Beads manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Eluting Beads Market Report

Report Metric Details
Report Name Drug Eluting Beads Market
CAGR 5%
Segment by Type
  • Oncozene Beads
  • Quadra Sphere
  • LC Beads
  • Others
Segment by Application
  • Hospitals
  • Specialized Clinics
  • Research Centers
  • Ambulatory Surgical Centers
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Surefire Medical, Terumo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Eluting Beads in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Drug Eluting Beads Market report?

Ans: The main players in the Drug Eluting Beads Market are Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Surefire Medical, Terumo

What are the Application segmentation covered in the Drug Eluting Beads Market report?

Ans: The Applications covered in the Drug Eluting Beads Market report are Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers

What are the Type segmentation covered in the Drug Eluting Beads Market report?

Ans: The Types covered in the Drug Eluting Beads Market report are Oncozene Beads, Quadra Sphere, LC Beads, Others

1 Drug Eluting Beads Market Overview
1.1 Product Definition
1.2 Drug Eluting Beads by Type
1.2.1 Global Drug Eluting Beads Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oncozene Beads
1.2.3 Quadra Sphere
1.2.4 LC Beads
1.2.5 Others
1.3 Drug Eluting Beads by Application
1.3.1 Global Drug Eluting Beads Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Research Centers
1.3.5 Ambulatory Surgical Centers
1.4 Global Drug Eluting Beads Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Beads Revenue 2020-2031
1.4.2 Global Drug Eluting Beads Sales 2020-2031
1.4.3 Global Drug Eluting Beads Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Eluting Beads Market Competition by Manufacturers
2.1 Global Drug Eluting Beads Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Eluting Beads Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Eluting Beads Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Eluting Beads, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Beads, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Beads, Product Type & Application
2.7 Global Key Manufacturers of Drug Eluting Beads, Date of Enter into This Industry
2.8 Global Drug Eluting Beads Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Beads Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Eluting Beads Players Market Share by Revenue
2.8.3 Global Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Beads Market Scenario by Region
3.1 Global Drug Eluting Beads Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Eluting Beads Sales by Region: 2020-2031
3.2.1 Global Drug Eluting Beads Sales by Region: 2020-2025
3.2.2 Global Drug Eluting Beads Sales by Region: 2026-2031
3.3 Global Drug Eluting Beads Revenue by Region: 2020-2031
3.3.1 Global Drug Eluting Beads Revenue by Region: 2020-2025
3.3.2 Global Drug Eluting Beads Revenue by Region: 2026-2031
3.4 North America Drug Eluting Beads Market Facts & Figures by Country
3.4.1 North America Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Eluting Beads Sales by Country (2020-2031)
3.4.3 North America Drug Eluting Beads Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug Eluting Beads Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Eluting Beads Sales by Country (2020-2031)
3.5.3 Europe Drug Eluting Beads Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Beads Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Beads Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Eluting Beads Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Eluting Beads Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug Eluting Beads Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Eluting Beads Sales by Country (2020-2031)
3.7.3 Latin America Drug Eluting Beads Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Beads Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Beads Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Eluting Beads Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Eluting Beads Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drug Eluting Beads Sales by Type (2020-2031)
4.1.1 Global Drug Eluting Beads Sales by Type (2020-2025)
4.1.2 Global Drug Eluting Beads Sales by Type (2026-2031)
4.1.3 Global Drug Eluting Beads Sales Market Share by Type (2020-2031)
4.2 Global Drug Eluting Beads Revenue by Type (2020-2031)
4.2.1 Global Drug Eluting Beads Revenue by Type (2020-2025)
4.2.2 Global Drug Eluting Beads Revenue by Type (2026-2031)
4.2.3 Global Drug Eluting Beads Revenue Market Share by Type (2020-2031)
4.3 Global Drug Eluting Beads Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Eluting Beads Sales by Application (2020-2031)
5.1.1 Global Drug Eluting Beads Sales by Application (2020-2025)
5.1.2 Global Drug Eluting Beads Sales by Application (2026-2031)
5.1.3 Global Drug Eluting Beads Sales Market Share by Application (2020-2031)
5.2 Global Drug Eluting Beads Revenue by Application (2020-2031)
5.2.1 Global Drug Eluting Beads Revenue by Application (2020-2025)
5.2.2 Global Drug Eluting Beads Revenue by Application (2026-2031)
5.2.3 Global Drug Eluting Beads Revenue Market Share by Application (2020-2031)
5.3 Global Drug Eluting Beads Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biocompatibles
6.1.1 Biocompatibles Company Information
6.1.2 Biocompatibles Description and Business Overview
6.1.3 Biocompatibles Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biocompatibles Drug Eluting Beads Product Portfolio
6.1.5 Biocompatibles Recent Developments/Updates
6.2 BTG International
6.2.1 BTG International Company Information
6.2.2 BTG International Description and Business Overview
6.2.3 BTG International Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BTG International Drug Eluting Beads Product Portfolio
6.2.5 BTG International Recent Developments/Updates
6.3 Merit Medical Systems
6.3.1 Merit Medical Systems Company Information
6.3.2 Merit Medical Systems Description and Business Overview
6.3.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
6.3.5 Merit Medical Systems Recent Developments/Updates
6.4 CeloNova BioSciences
6.4.1 CeloNova BioSciences Company Information
6.4.2 CeloNova BioSciences Description and Business Overview
6.4.3 CeloNova BioSciences Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CeloNova BioSciences Drug Eluting Beads Product Portfolio
6.4.5 CeloNova BioSciences Recent Developments/Updates
6.5 ABK Biomedical
6.5.1 ABK Biomedical Company Information
6.5.2 ABK Biomedical Description and Business Overview
6.5.3 ABK Biomedical Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ABK Biomedical Drug Eluting Beads Product Portfolio
6.5.5 ABK Biomedical Recent Developments/Updates
6.6 Boston Scientific
6.6.1 Boston Scientific Company Information
6.6.2 Boston Scientific Description and Business Overview
6.6.3 Boston Scientific Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boston Scientific Drug Eluting Beads Product Portfolio
6.6.5 Boston Scientific Recent Developments/Updates
6.7 Medtronic
6.7.1 Medtronic Company Information
6.7.2 Medtronic Description and Business Overview
6.7.3 Medtronic Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Medtronic Drug Eluting Beads Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 Merit Medical Systems
6.8.1 Merit Medical Systems Company Information
6.8.2 Merit Medical Systems Description and Business Overview
6.8.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
6.8.5 Merit Medical Systems Recent Developments/Updates
6.9 Surefire Medical
6.9.1 Surefire Medical Company Information
6.9.2 Surefire Medical Description and Business Overview
6.9.3 Surefire Medical Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Surefire Medical Drug Eluting Beads Product Portfolio
6.9.5 Surefire Medical Recent Developments/Updates
6.10 Terumo
6.10.1 Terumo Company Information
6.10.2 Terumo Description and Business Overview
6.10.3 Terumo Drug Eluting Beads Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Terumo Drug Eluting Beads Product Portfolio
6.10.5 Terumo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Beads Industry Chain Analysis
7.2 Drug Eluting Beads Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Beads Production Mode & Process Analysis
7.4 Drug Eluting Beads Sales and Marketing
7.4.1 Drug Eluting Beads Sales Channels
7.4.2 Drug Eluting Beads Distributors
7.5 Drug Eluting Beads Customer Analysis
8 Drug Eluting Beads Market Dynamics
8.1 Drug Eluting Beads Industry Trends
8.2 Drug Eluting Beads Market Drivers
8.3 Drug Eluting Beads Market Challenges
8.4 Drug Eluting Beads Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Biocompatibles
BTG International
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic Inc
Surefire Medical
Terumo
Merit Medical Systems
List of Tables
 Table 1. Global Drug Eluting Beads Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug Eluting Beads Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug Eluting Beads Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug Eluting Beads Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug Eluting Beads Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug Eluting Beads Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug Eluting Beads Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug Eluting Beads Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug Eluting Beads, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Eluting Beads, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Eluting Beads, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Eluting Beads, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Eluting Beads by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Beads as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Eluting Beads Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug Eluting Beads Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug Eluting Beads Sales Market Share by Region (2020-2025)
 Table 19. Global Drug Eluting Beads Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug Eluting Beads Sales Market Share by Region (2026-2031)
 Table 21. Global Drug Eluting Beads Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug Eluting Beads Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug Eluting Beads Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug Eluting Beads Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug Eluting Beads Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug Eluting Beads Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug Eluting Beads Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug Eluting Beads Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug Eluting Beads Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug Eluting Beads Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug Eluting Beads Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug Eluting Beads Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug Eluting Beads Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug Eluting Beads Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug Eluting Beads Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug Eluting Beads Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug Eluting Beads Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug Eluting Beads Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug Eluting Beads Sales Market Share by Type (2020-2025)
 Table 53. Global Drug Eluting Beads Sales Market Share by Type (2026-2031)
 Table 54. Global Drug Eluting Beads Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug Eluting Beads Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug Eluting Beads Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug Eluting Beads Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug Eluting Beads Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Drug Eluting Beads Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Drug Eluting Beads Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug Eluting Beads Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug Eluting Beads Sales Market Share by Application (2020-2025)
 Table 63. Global Drug Eluting Beads Sales Market Share by Application (2026-2031)
 Table 64. Global Drug Eluting Beads Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug Eluting Beads Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug Eluting Beads Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug Eluting Beads Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug Eluting Beads Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Drug Eluting Beads Price (USD/Unit) by Application (2026-2031)
 Table 70. Biocompatibles Company Information
 Table 71. Biocompatibles Description and Business Overview
 Table 72. Biocompatibles Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Biocompatibles Drug Eluting Beads Product
 Table 74. Biocompatibles Recent Developments/Updates
 Table 75. BTG International Company Information
 Table 76. BTG International Description and Business Overview
 Table 77. BTG International Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. BTG International Drug Eluting Beads Product
 Table 79. BTG International Recent Developments/Updates
 Table 80. Merit Medical Systems Company Information
 Table 81. Merit Medical Systems Description and Business Overview
 Table 82. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Merit Medical Systems Drug Eluting Beads Product
 Table 84. Merit Medical Systems Recent Developments/Updates
 Table 85. CeloNova BioSciences Company Information
 Table 86. CeloNova BioSciences Description and Business Overview
 Table 87. CeloNova BioSciences Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. CeloNova BioSciences Drug Eluting Beads Product
 Table 89. CeloNova BioSciences Recent Developments/Updates
 Table 90. ABK Biomedical Company Information
 Table 91. ABK Biomedical Description and Business Overview
 Table 92. ABK Biomedical Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. ABK Biomedical Drug Eluting Beads Product
 Table 94. ABK Biomedical Recent Developments/Updates
 Table 95. Boston Scientific Company Information
 Table 96. Boston Scientific Description and Business Overview
 Table 97. Boston Scientific Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Boston Scientific Drug Eluting Beads Product
 Table 99. Boston Scientific Recent Developments/Updates
 Table 100. Medtronic Company Information
 Table 101. Medtronic Description and Business Overview
 Table 102. Medtronic Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Medtronic Drug Eluting Beads Product
 Table 104. Medtronic Recent Developments/Updates
 Table 105. Merit Medical Systems Company Information
 Table 106. Merit Medical Systems Description and Business Overview
 Table 107. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Merit Medical Systems Drug Eluting Beads Product
 Table 109. Merit Medical Systems Recent Developments/Updates
 Table 110. Surefire Medical Company Information
 Table 111. Surefire Medical Description and Business Overview
 Table 112. Surefire Medical Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Surefire Medical Drug Eluting Beads Product
 Table 114. Surefire Medical Recent Developments/Updates
 Table 115. Terumo Company Information
 Table 116. Terumo Description and Business Overview
 Table 117. Terumo Drug Eluting Beads Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Terumo Drug Eluting Beads Product
 Table 119. Terumo Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Drug Eluting Beads Distributors List
 Table 123. Drug Eluting Beads Customers List
 Table 124. Drug Eluting Beads Market Trends
 Table 125. Drug Eluting Beads Market Drivers
 Table 126. Drug Eluting Beads Market Challenges
 Table 127. Drug Eluting Beads Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Eluting Beads
 Figure 2. Global Drug Eluting Beads Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Eluting Beads Market Share by Type: 2024 & 2031
 Figure 4. Oncozene Beads Product Picture
 Figure 5. Quadra Sphere Product Picture
 Figure 6. LC Beads Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Drug Eluting Beads Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Drug Eluting Beads Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Specialized Clinics
 Figure 12. Research Centers
 Figure 13. Ambulatory Surgical Centers
 Figure 14. Global Drug Eluting Beads Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Drug Eluting Beads Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Drug Eluting Beads Sales (2020-2031) & (K Units)
 Figure 17. Global Drug Eluting Beads Average Price (USD/Unit) & (2020-2031)
 Figure 18. Drug Eluting Beads Report Years Considered
 Figure 19. Drug Eluting Beads Sales Share by Manufacturers in 2024
 Figure 20. Global Drug Eluting Beads Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Drug Eluting Beads Players: Market Share by Revenue in Drug Eluting Beads in 2024
 Figure 22. Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Drug Eluting Beads Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Drug Eluting Beads Sales Market Share by Country (2020-2031)
 Figure 25. North America Drug Eluting Beads Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Drug Eluting Beads Sales Market Share by Country (2020-2031)
 Figure 29. Europe Drug Eluting Beads Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Drug Eluting Beads Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Drug Eluting Beads Revenue Market Share by Region (2020-2031)
 Figure 37. China Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Drug Eluting Beads Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Drug Eluting Beads Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Drug Eluting Beads Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Drug Eluting Beads Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Drug Eluting Beads Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Drug Eluting Beads by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Drug Eluting Beads by Type (2020-2031)
 Figure 59. Global Drug Eluting Beads Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Drug Eluting Beads by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Drug Eluting Beads by Application (2020-2031)
 Figure 62. Global Drug Eluting Beads Price (USD/Unit) by Application (2020-2031)
 Figure 63. Drug Eluting Beads Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Drug Eluting Beads Microcatheters and Radiopaque Beads in Interventional Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug elutable Beads Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug eluting Microsphere Market Research Report 2025
Drug Eluting Stent System Market
Global Intracranial Drug Eluting Stents Market Research Report 2024
Global Drug Eluting Coronary Stent System Market Research Report 2024
Drug Eluting Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Eluting Peripheral Stents Market Research Report 2025
Drug Eluting Balloon Catheters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Eluting Coronary Stent Market Research Report 2025
Global TACE Embolic Microspheres Market Research Report 2024
Coronary Intervention Drug Eluting Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Implantable Drug Eluting Stent Market Research Report 2024
Global Implantable Coronary Drug Eluting Stent Market Research Report 2024
Global Peripheral Intervention Drug Eluting Devices Market Insights Forecast to 2030
Global Drug Loadable Embolic Microspheres Market Research Report 2024
Global Embolization Spheres Market Research Report 2024
Global Implantable Drug Eluting Devices Market Insights Forecast to 2030
Global Implantable Drug Eluting Balloon Market Research Report 2024
Global Coronary Drug Stent System Market Research Report 2024

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions